Endurance Ablation Facilitates Long-lasting Circumferential Pulmonary Vein Isolation and Better Clinical Outcomes in Patients with Paroxysmal Atrial Fibrillation
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background Recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation was found to be related to the reconnection of circumferential pulmonary vein isolation (CPVI). We hypothesized that endurance ablation with moderately increased radiofrequency (RF) power would facilitate long-lasting CPVI and better clinical outcomes. Methods We included 508 patients with paroxysmal AF (76.0% men; mean age, 56.2±9.5 years) who underwent CPVI alone. We compared endurance ablation group (ENDU-abl; n=254, 30 s ablation at each point with 35 W on anterior pulmonary veins (PVs) antrum and 25–30 W on posterior left atrium [LA]) with age-, sex-, and follow-up duration-matched conventional ablation group (CONV-abl; n=254, elimination of PV potential [PVP] with 25 W). Results 1. Total procedure time (p<0.001) and ablation time (p<0.001) were significantly longer, and major complication rate was comparable (p=0.088) between ENDU-abl and CONV-abl groups; 2. At 3-month follow-up, heart rate variability, high-frequency (HF) domain (p=0.008) and low-frequency (LF)/HF ratio (p<0.001) were significantly lower, while LA reverse remodeling was more significant at 1-year follow-up echocardiogram (p=0.013) in ENDU-abl group; 3. During 37.2±17.5 months of follow-up, the clinical recurrence of AF was significantly lower in ENDU-abl group (19.3% vs. 35.4%, log-rank p<0.001); 4. Among 38 patients who underwent redo-ablation at 15.1±12.1 months, reconnected PVPs were found in 4/11 patients (36.4%) from ENDU-abl group and in 26/27 patients (96.3%) from CONV-abl group (p<0.001). Conclusion Despite longer procedure time and relatively higher complication risk, endurance ablation with moderately increased RF power facilitates long-lasting CPVI, more significant autonomic neural remodeling and LA reverse remodeling, and better clinical outcome than conventional ablation in patients with paroxysmal AF.
Abstract
Background Recurrence of atrial fibrillation (AF) after radiofrequency catheter ablation was found to be related to the reconnection of circumferential pulmonary vein isolation (CPVI). We hypothesized that endurance ablation with moderately increased radiofrequency (RF) power would facilitate long-lasting CPVI and better clinical outcomes. Methods We included 508 patients with paroxysmal AF (76.0% men; mean age, 56.2±9.5 years) who underwent CPVI alone. We compared endurance ablation group (ENDU-abl; n=254, 30 s ablation at each point with 35 W on anterior pulmonary veins (PVs) antrum and 25–30 W on posterior left atrium [LA]) with age-, sex-, and follow-up duration-matched conventional ablation group (CONV-abl; n=254, elimination of PV potential [PVP] with 25 W). Results 1. Total procedure time (p<0.001) and ablation time (p<0.001) were significantly longer, and major complication rate was comparable (p=0.088) between ENDU-abl and CONV-abl groups; 2. At 3-month follow-up, heart rate variability, high-frequency (HF) domain (p=0.008) and low-frequency (LF)/HF ratio (p<0.001) were significantly lower, while LA reverse remodeling was more significant at 1-year follow-up echocardiogram (p=0.013) in ENDU-abl group; 3. During 37.2±17.5 months of follow-up, the clinical recurrence of AF was significantly lower in ENDU-abl group (19.3% vs. 35.4%, log-rank p<0.001); 4. Among 38 patients who underwent redo-ablation at 15.1±12.1 months, reconnected PVPs were found in 4/11 patients (36.4%) from ENDU-abl group and in 26/27 patients (96.3%) from CONV-abl group (p<0.001). Conclusion Despite longer procedure time and relatively higher complication risk, endurance ablation with moderately increased RF power facilitates long-lasting CPVI, more significant autonomic neural remodeling and LA reverse remodeling, and better clinical outcome than conventional ablation in patients with paroxysmal AF.
참고문헌 (22)
- Nademanee K, "A new approach for catheter ablation of atrial fibrillation : mapping of the electrophysiologic substrate", J Am Coll Cardiol, 43, pp.2044~2053 (2004)
- Knecht S, "Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation", Eur Heart J, 29, pp.2359~2366 (2008)
- Oral H, "Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation", Circulation, 105, pp.1077~1081 (2002)
- Cappato R, "Prospective assessment of late conduction recurrence across radiofrequency lesions producing electrical disconnection at the pulmonary vein ostium in patients with atrial fibrillation", Circulation, 108, pp.1599~1604 (2003)
- Hwang ES, "Significant reduction of atrial defibrillation threshold and inducibility by catheter ablation of atrial fibrillation", Pacing Clin Electrophysiol, 35, pp.1428~1435 (2012)
- Shim J, "Long duration of radiofrequency energy delivery is an independent predictor of clinical recurrence after catheter ablation of atrial fibrillation: over 500 cases experience", Int J Cardiol, 167, pp.2667~2672 (2013)
- Kang KW, "Long-term changes in heart rate variability after radiofrequency catheter ablation for atrial fibrillation: 1-year followup study with irrigation tip catheter", J Cardiovasc Electrophysiol, 25, pp.693~700 (2014)
- Lang RM, "Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging", J Am Soc Echocardiogr, 28, pp.1~39 e14 (2015)
- European Heart Rhythm Association, "HRS", EHRA, Heart Rhythm, pp.2007, 4[DOI]
- "Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology", Circulation, 93, pp.1043~1065 (1996)
- January CT, "2014 AHA", ACC, American Heart Association Task Force on practice guidelines and the Heart Rhythm Society, pp.Circulation, 2014[DOI]
- Kirchhof P, "2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS", Eur Heart J, 37, pp.2893~2962 (2016)
- Morillo CA, "Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation(RAAFT-2) : a randomized trial", JAMA, 311, pp.692~700 (2014)
- Brooks AG, "Outcomes of long-standing persistent atrial fibrillation ablation : a systematic review", Heart Rhythm, 7, pp.835~846 (2010)
- Hwang ES, "Risks and benefits of an open irrigation tip catheter in intensive radiofrequency catheter ablation in patients with nonparoxysmal atrial fibrillation", Circ J, 74, pp.644~649 (2010)
- Fein AS, "Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation", J Am Coll Cardiol, 62, pp.300~305 (2013)
- Kim TH, "Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: An analysis of over 600-patients", Int J Cardiol, 176, pp.841~846 (2014)
- Mun HS, "Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study", Heart, 98, pp.480~484 (2012)
- Kim TH, "Linear ablation in addition to circumferential pulmonary vein isolation (Dallas lesion set) does not improve clinical outcome in patients with paroxysmal atrial fibrillation: a prospective randomized study", Europace, 17, pp.388~395 (2015)
- Verma A, "Substrate and Trigger Ablation for Reduction of Atrial Fibrillation(STAR AF) : a randomized, multicentre, international trial", Eur Heart J, 31, pp.1344~1356 (2010)
- Ouyang F, "Long-term results of catheter ablation in paroxysmal atrial fibrillation : lessons from a 5-year follow-up", Circulation, 122, pp.2368~2377 (2010)
- Pappone C, "Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation", Circulation, 109, pp.327~334 (2004)